New Option Approved for Long-Term COPD Treatment
A new once-daily inhaled therapy for COPD should be available for dispensing by the third quarter of 2013. The FDA recently approved Breo Ellipta for the long-term, maintenance treatment of airflow obstruction in patients with COPD, as well as reduction of COPD exacerbations.
Here is more information.